Select another language
Select another language

Early Access Programmes

Reimbursed early access programs

In the dynamic field of early access programmes, Justin Stindt Consultants emerges as a key consulting agency. Our experts specialize in Pharma, Biotech, and Medtech market entry, providing essential guidance for navigating these complex processes. As a global consulting firm, we offer specialized knowledge and strategic insights for successful market access.
Our team of specialists serves as dedicated partners in your journey, ensuring informed decisions in early product introductions both via reimbursed early access programs such as AAC/AAP in France or compassionate use programs in other markets. This international agency is recognized for its tailored approach in the healthcare sector, supporting clients through every step of the early access programme.
At Justin Stindt Consultants, we prioritize efficient and effective market entry, leveraging our expertise to guide your innovative treatments swiftly to the market.